Investors interested in Medical - Drugs stocks are likely familiar with USANA Health Sciences (USNA) and United Therapeutics (UTHR). But which of these two stocks is more attractive to value investors ...

United Therapeutics Corporation (NASDAQ:UTHR) is one of the Top 10 Stocks Warren Buffett Would Buy in 2026. On February 26, 2026, H.C. Wainwright raised the price target on United Therapeutics ...

United Therapeutics (UTHR) came out with quarterly earnings of $7.7 per share, beating the Zacks Consensus Estimate of $6.78 per share. This compares to earnings of $6.19 per share a year ago. These ...

Total Revenue: $790 million for Q4 2025, representing 7% growth from Q4 2024. Annual Revenue: Surpassed $3 billion for the first time, with 11% growth over 2024. Tyvaso Revenue: $464 million for Q4, a ...

Director Christopher Causey of United Therapeutics (NASDAQ:UTHR) sold 20 shares of common stock on March 4, 2026, at an average price of $490.1685, for a total value of $9803. Prices ranged from ...

[Audio Gap] get started. So thank you, everyone, for joining us in the room and online at TD Cowen's 46th Annual Healthcare Conference. I'm Joe Thome, one of the senior biotech analysts here on the ...

Good morning, everyone, and welcome to the United Therapeutics Corporation Fourth Quarter 2025 Corporate Update Conference Call. My name is Jamie, and I will be your conference operator today.

Biotechnology company United Therapeutics (NASDAQ:UTHR) missed Wall Street’s revenue expectations in Q4 CY2025, but sales rose 7.4% year on year to $790.2 million. Its GAAP profit of $7.70 per share ...